Papers: 18 Oct 2013 - 25 Oct 2013
Early pathological alterations of lower lumbar cords detected by ultrahigh-field MRI in a mouse multiple sclerosis model.
Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease.
Interferon-Beta-Induced Pulmonary Sarcoidosis in a 30 Year-Old Male With Multiple Sclerosis: A Case Report.
A Randomized, Double-Blind, Placebo-Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis.
Acute-Phase Protein Hemopexin Is a Negative Regulator of Th17 Response and Experimental Autoimmune Encephalomyelitis Development.
Abstracts of ECTRIMS (Congress of the European Committee for Treatment and Research in Multiple Sclerosis) 2013. October 2-5, 2013. Copenhagen, Denmark.
Assessment of structural and functıonal vısual outcomes ın relapsıng remıttıng multıple sclerosıs wıth vısual evoked potentıals and optıcal coherence tomography.
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.
Group specific vein-atlasing: An application for analyzing the venous system under normal and multiple sclerosis conditions.
Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: An open-label study.
Decoding Signaling and Function of the Orphan G Protein-Coupled Receptor GPR17 with a Small-Molecule Agonist.
Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.
Evaluation of Rho-Kinase Activity in Mice Brain Using N-[(11)C]Methyl-hydroxyfasudil with Positron Emission Tomography.
Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: Implications for remyelination at lesions sites.
Brain stem infarction associated with familial Mediterranean fever and central nervous system vasculitis.
Identification of Inflammatory Neuronal Injury and Prevention of Neuronal Damage in Multiple Sclerosis: Hope for Novel Therapies?
Warmer outdoor temperature is associated with task-related increased BOLD activation in patients with multiple sclerosis.
Tolerability and pharmacokinetics of delayed-release dimethyl fumarate administered with and without aspirin in healthy volunteers.
Evaluation of clinical parameters during and after treatment of attack in patients with clinically isolated syndrome: Comparison of the results with that of multiple sclerosis patients.
Myelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis.
Long-term endurance exercise improves aerobic capacity in patients with relapsing-remitting Multiple Sclerosis: Impact of baseline fatigue.
Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States.
Multimodal noninvasive and invasive imaging of extracranial venous abnormalities indicative of CCSVI: results of the PREMiSe pilot study.
Cerebrospinal fluid analysis in infectious diseases of the nervous system: when to ask, what to ask, what to expect.
Multiple sclerosis in the Southern and Northern hemispheres: the month of birth at different latitudes has the same influence on the prevalence and progression of the disease in the Northern and Southern hemispheres?
Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: The DEFINE study.
Diffusion tensor magnetic resonance imaging may show abnormalities in the normal-appearing cervical spinal cord from patients with multiple sclerosis.
Central nervous system infectious diseases mimicking multiple sclerosis: recognizing distinguishable features using MRI.
Multiple sclerosis in South America: month of birth in different latitudes does not seem to interfere with the prevalence or progression of the disease.
Multiple sclerosis: Genotyping study identifies a plethora of new susceptibility variants for multiple sclerosis.
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated to hereditary neuropathy with liability to pressure palsies (HNPP) and revealed after influenza AH1N1 vaccination.
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: Electrophysiological evidence.
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.
Acute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systems.
Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosis.
Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes.
Glutathione Homeostasis Disruption of Erythrocytes, but Not Glutathione Peroxidase Activity Change, Is Closely Accompanied with Neurological and Radiological Scoring of Acute CNS Inflammation.
Review of daclizumab and its therapeutic potential in the treatment of relapsing-remitting multiple sclerosis.
Local assessment of myelin health in a multiple sclerosis mouse model using a 2D Fourier transform approach.
Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study.